Phase 2 Study demonstrating the Safety and Efficacy of TAK-442 in ACS

• Research type

  Research Study

• Full title

  A Phase 2, Double-blind, Randomized, Placebo-controlled Study of the Safety and Efficacy of TAK-442 in Subjects With Acute Coronary Syndromes

• IRAS ID

  2964

• Contact name

  Alastair C H Pell

• Contact email

  alastair.pell@lanarkshire.scot.nhs.uk

• Eudract number

  2008-000091-24

• Clinicaltrials.gov Identifier

  NCT00677053

• Research summary

  Not published at request of researcher

• REC name

  Scotland A REC

• REC reference

  08/MRE00/68

• Date of REC Opinion

  2 Dec 2008

• REC opinion

  Further Information Favourable Opinion